Baxter Recalls Dysfunctional Buretrol Solution Sets

En Español

Buretrol Solution Sets have been employed for years to prevent errors or improper administration of medication to patients during intravenous (IV) injections. However, concern has been raised for Baxter Healthcare Corporation over malfunctioning Buretrol Solution Sets which could cause more harm than help. On September 7, 2012, officials ordered a Class 1 recall of all lots of specified Buretrol Solution Sets to avoid adverse events.

Manufacturers claim that the ball-valve element may allow air to enter the tubing and into the patient’s bloodstream. This slight error can result in an air embolism (gas embolism) in which bubbles of air enter the blood stream and become trapped in blood vessels. This serious condition can result in severe side effects and death.

doctor giving injection in buretrol

Which Buretrol Solution Systems Were Recalled?

All lots of the following products are included in the recall:

  • Product 2C7519- Interlink System Buretrol Solution Set with 150 mL Burette
  • Product 2H7519- Interlink System Buretrol Solution Set with 150 mL Burette- Non-DEHP
  • Product 2C8819- Clearlink System Buretrol Solution Set with 150 mL Burette
  • Product 2H8819- Clearlink System Buretrol Solution Set with 150 mL Burette- Non-DEHP

The recalled Buretrol Solution Systems were distributed between May 1, 2003 and August 16, 2012.

What Should I Do with Recalled Products?

Patients and healthcare providers with recalled Buretrol Solution Systems should end use of the product and contact Center for One Baxter by calling 1-800-422-9837. The FDA released a Urgent Product Recall letter on September 7, 2012 to advise all customers to discontinue use and follow proper returning procedures which may be found online here. Report adverse reactions by contacting the U.S. Food and Drug Administration’s MedWatch Adverse Event Reporting Program.

Learn more about medical product recalls and information at bad-drug.net.

0."/>